The Global Initiatives for Proliferation Prevention (GIPP) program under Department of Energy’s National Nuclear Security Administration (NNSA) and AMIC will each contribute $760,000 to the project.
The new production method funded by this project is based on the alternative method for producing medical isotopes (AMPMI) technology being developed at the Kharkiv Institute. The AMPMI method generates an intense neutron beam at high fluence rate under controlled conditions, with an advanced target design for efficient production of neutron-rich medical isotopes.
Jim Katzaroff, CEO at AMIC, said: The AMPMI neutron technology complements our current proton LINAC at our first production facility in Kennewick, Washington. We anticipate that the AMPMI neutron technology will provide the opportunity to produce a wide variety of medical isotopes on a smaller scale, closer to the point of use, than isotope production in nuclear reactors.